The Valley Desk

Clinical trial reportThe Lancet. Respiratory medicinePublished

Efzofitimod versus placebo in patients with pulmonary sarcoidosis (EFZO-FIT): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Lewis Katz School of Medicine, with Temple University linked by the institution reference. Affiliation source

Publication record

Type
Clinical trial report
Venue
The Lancet. Respiratory medicine
Published
PubMed ID
42933455
Added to directory
Source checked

Report a correction or request removal